HEPATIC RESECTION FOR HEPATOCELLULAR-CARCINOMA

被引:57
作者
SUENAGA, M [1 ]
NAKAO, A [1 ]
HARADA, A [1 ]
NONAMI, T [1 ]
OKADA, Y [1 ]
SUGIURA, H [1 ]
UEHARA, S [1 ]
TAKAGI, H [1 ]
机构
[1] NAGOYA UNIV,SCH MED,DEPT SURG 2,NAGOYA,AICHI 466,JAPAN
关键词
D O I
10.1007/BF02067120
中图分类号
R61 [外科手术学];
学科分类号
摘要
One hundred and eighteen patients underwent hepatic resection for hepatocellular carcinoma from 1979 to 1987. Ninety-eight of these patients had co-existing cirrhosis of the liver; 18 patients underwent lobectomy, 28 patients had segmentectomy, and 52 patients had subsegmentectomy. In the 21 non-cirrhotic patients, 11 patients underwent lobectomy, 5 patients had segmentectomy, and 5 patients had subsegmentectomy. The operative mortality rate of patients with cirrhosis was 11 % and of patients without cirrhosis was 5%. There was no significant difference in hepatic function tests between survivors and nonsurvivors. Lobectomy of < 55% of the parenchymal hepatic resection rate was well tolerated in the patients with cirrhosis. One-year, 3-year, and 5-year survival rates of patients with hepatocellular carcinoma and co-existing cirrhosis were 57.9%, 36.8% and 20.0% following lobectomy, 82.8%, 82.8% and 57.6% following segmentectomy, and 72.0%, 46.2% and 24.0% following subsegmentectomy. The tumor recurrence rate appeared to be lower after segmentectomy than subsegmentectomy. Multiple gross lesions, tumors > 5 cm, and presence of gross vascular invasion were poor prognostic signs in terms of survival rates as well as recurrence rates. Of the 51 patients with tumor recurrence limited to the residual liver, 13 patients underwent repeat resection, and 23 patients were treated by transcatheter arterial chemoembolization. The survival rates of the patients undergoing repeat resection were significantly better than those of other groups.
引用
收藏
页码:97 / 105
页数:9
相关论文
共 36 条
  • [1] ALPERT EA, 1975, HEPATOCELLULAR CARCI, P353
  • [2] EVIDENCE THAT HEPATITIS-B VIRUS HAS A ROLE IN LIVER-CELL CARCINOMA IN ALCOHOLIC LIVER-DISEASE
    BRECHOT, C
    NALPAS, B
    COUROUCE, AM
    DUHAMEL, G
    CALLARD, P
    CARNOT, F
    TIOLLAIS, P
    BERTHELOT, P
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (23) : 1384 - 1387
  • [3] COUINAUD C, 1954, PRESSE MED, V62, P709
  • [4] FORTNER GF, 1978, ANN SURG, V188, P375
  • [5] BASE SUBSTITUTION MUTATIONS INDUCED BY METABOLICALLY ACTIVATED AFLATOXIN-B1
    FOSTER, PL
    EISENSTADT, E
    MILLER, JH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09): : 2695 - 2698
  • [6] HEALEY J E Jr, 1954, J Int Coll Surg, V22, P542
  • [7] MUTATIONAL HOTSPOT IN THE P53 GENE IN HUMAN HEPATOCELLULAR CARCINOMAS
    HSU, IC
    METCALF, RA
    SUN, T
    WELSH, JA
    WANG, NJ
    HARRIS, CC
    [J]. NATURE, 1991, 350 (6317) : 427 - 428
  • [8] EXPERIENCE WITH 150 LIVER RESECTIONS
    IWATSUKI, S
    SHAW, BW
    STARZL, TE
    [J]. ANNALS OF SURGERY, 1983, 197 (03) : 247 - 253
  • [9] IWATSUKI S, 1985, ANN SURG, V202, P401, DOI 10.1097/00000658-198510000-00001
  • [10] LIMITED HEPATIC RESECTION EFFECTIVE FOR SELECTED CIRRHOTIC-PATIENTS WITH PRIMARY LIVER-CANCER
    KANEMATSU, T
    TAKENAKA, K
    MATSUMATA, T
    FURUTA, T
    SUGIMACHI, K
    INOKUCHI, K
    [J]. ANNALS OF SURGERY, 1984, 199 (01) : 51 - 56